Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021

NCT05795894 | Unknown

• 1 other identifier: 22-HPNCL-07
• Study Type: observational
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

A qualitative study, combining psychiatric and anthropological perspectives, focused on the lived experiences of patients who had recourse to HPNCL emergencies during the period of November 2021, as well as the experiences and perceptions of those around them - such as their family, teachers or school and nursing staff. This multi-site approach will provide a multidimensional perspective on the experience of individuals and those around them, as well as a triangulation of data. The hypotheses to explain the increase in the rate of suicidal crisis will be addressed through semi-structured interviews proposed to the participants of the study.

Conditions

Suicide; COVID-19

Keywords

pediatric

Outcome Measures

Primary Outcomes (1)

• Situational Anxiety and Trait Anxiety Inventory

  This inventory aims to assess anxiety as a "personality trait" (feelings of apprehension, tension, nervousness and worry that the subject usually feels), and anxiety as a ' "emotional state" linked to a particular situation (feelings of apprehension, tension or nervousness that the subject feels at a specific moment). This is a questionnaire comprising 20 items for the "state" form and 20 items for the "trait" form. The instruction is to answer "in general, in the usual way" for the "trait" scale and "at the moment" for the "state" scale. Each score can therefore vary from 20 to 80 with a "very high" anxiety norm when the threshold is \> 65, "high" between 56 and 65, "medium" between 46 and 55, "low" between 36 and 45 and "very low" for a score \< or = 35.

  at inclusion

Secondary Outcomes (3)

• Beck Depression Inventory

  at inclusion

• "Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent

  at inclusion

• Post-traumatic Check List Scale

  at inclusion

Study Arms (1)

patents

Questionnaires

Behavioral: STAI-Y; Behavioral: BDI scale; Behavioral: M.I.N.I.Kid; Behavioral: PCL-5

Interventions

STAI-Y BEHAVIORAL

Situational Anxiety and Trait Anxiety Inventory

patents

BDI scale BEHAVIORAL

• Beck Depression Inventory scale

patents

M.I.N.I.Kid BEHAVIORAL

Suicidal risk" module of the Mini-International Neuropsychiatric Interview child/adolescent version

patents

PCL-5 BEHAVIORAL

Post-traumatic Check List Scale

patents

Eligibility Criteria

• Age: 13 Years - 17 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

* The patient who consulted the emergency room during the month of November 2021 * The parent(s) of the study participant * One or more health professionals taking care of the patient * The school attended by the patient who will be questioned about the suicidal problem and Covid-19 in general or not about the patient in particular. * Child welfare professionals (ASE) potentially involved in the care of the study participant

You may qualify if:

• Any patient having consulted in the child psychiatric emergency room of the HPNCL between November 1, 2021 and November 30, 2021 for suicidal thoughts.
• Age between 13 years and 17 years and 11 months
• Good understanding of written and oral French
• Collection of the informed consent of the patient and of one of the two parents or holder of parental authority

You may not qualify if:

• Refusal of participation by the patient or one of the legal guardians

Sponsors & Collaborators

• Fondation Lenval: lead

Study Sites (1)

hôpital Lenval

Nice, 06200, France

RECRUITING

MeSH Terms

Conditions

Suicide; COVID-19

Condition Hierarchy (Ancestors)

Self-Injurious Behavior; Behavioral Symptoms; Behavior; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Louise-Emilie DUMAS, MD

  Fondation Lenval

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Louise-Emilie DUMAS, MD

CONTACT

0492030372; Louise-Emilie.dumas@hpu.lenval.com

Brigitte REMY, MD

CONTACT

Brigitte.REMY@hpu.lenval.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 21, 2023
• First Posted: April 3, 2023
• Study Start: July 12, 2022
• Primary Completion: March 1, 2024
• Study Completion: March 1, 2024
• Last Updated: January 29, 2024

Record last verified: 2024-01

Locations

FR (1)